A randomized, controlled, comparative, proof-of-concept study to evaluate the efficacy and safety of Nisha-Amalaki capsules in prediabetic patients for preventing progression to diabetes

BACKGROUND: Prediabetes is an intermediate state of hyperglycemia, which acts as a precursor to Diabetes mellitus if left untreated. Nisha (Curcuma longa) and Amalaki (Emblica officinalis) combination has been advocated as drugs of choice to treat the early manifestations of Diabetes mellitus. OBJEC...

Descripción completa

Detalles Bibliográficos
Autores principales: Munshi, Renuka, Karande-Patil, Shilpa, Kumbhar, Dipti, Deshmukh, Amol, Hingorani, Lal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587713/
https://www.ncbi.nlm.nih.gov/pubmed/37857033
http://dx.doi.org/10.1016/j.jaim.2023.100806

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587713/
https://www.ncbi.nlm.nih.gov/pubmed/37857033
http://dx.doi.org/10.1016/j.jaim.2023.100806

Ejemplares similares